SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



       Date of Report (Date of earliest event reported): October 24, 2001






                                  MedQuist Inc.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)






    New Jersey                      0-19941                   22-2531298
------------------                -----------             -------------------
(State or other                   (Commission              (I.R.S. Employer
  jurisdiction                        File                Identification No.)
of incorporation                     Number)
or organization)






                              Five Greentree Centre
                                    Suite 311
                                Marlton, NJ 08053
               ---------------------------------------------------
               (address of principal executive offices) (Zip Code)





       Registrants's telephone number, including area code: (856) 810-8000


Item 5.  Other Events.
----------------------

Pursuant to Regulation FD Rules 100-103:

         Attached as Exhibit 5.1 is the script and related financial information
         for the Registrant's third quarter investor conference call held on
         October 24, 2001 at 11:00 a.m. (ET).

         Attached as Exhibit 5.2 is the Registrant's earnings release for the
         third quarter ended September 30, 2001.

Pursuant to Section 27A of the Securities Act of 1933 and 21E of the Securities
Exchange Act of 1934, attached as Exhibit 5.3 is a note concerning
forward-looking statements and additional information regarding factors that
could cause actual results to differ materially from those in such
forward-looking statements.






































                                      -2-


                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                   MEDQUIST INC.



Date: October 24, 2001             By:  /s/Brian J. Kearns
                                   --------------------------------------------
                                   Name:  Brian J. Kearns
                                   Title: Senior Vice President,
                                          Treasurer and Chief Financial Officer










































                                      -3-